| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.4 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | Panobinostat | FIMM | pan-cancer | AAC | 0.1 | 0.4 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.046 | 0.4 |